Pluri (PLUR) Notes Payables (2018)
Pluri (PLUR) posted quarterly Notes Payables of $243000.0 for Q2 2018.
Pluri (PLUR) Notes Payables (2018) Analysis & Trends
Pluri (PLUR) has reported Notes Payables for 1 consecutive years, with $243000.0 the latest figure, recorded in Q2 2018.
- In Q2 2018, Notes Payables changed N/A year-over-year to $243000.0; the TTM figure through Jun 2018 stood at $243000.0 (changed N/A YoY), while the FY2018 annual figure was $243000.0, changed N/A from the prior year.
- Notes Payables was little changed at $243000.0 in Q2 2018 per PLUR's latest filing.
- Across five years, Notes Payables topped out at $243000.0 in Q2 2018 and bottomed at $243000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Pluri | 16.02 Mn | 3.54 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 243,000.00 |